According to previous reports, up to 44% of the patients had a deletion of UGT2B17 in Chinese HBV affected HCC samples [4], and deletion of this gene was reported to be associated with increased prostate cancer risk, TP53 mutation, and relapse of head and neck carcinoma. Here, TP53 is linked to Familial prostate cancer.